Search results
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 1 day agoPfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Pfizer (PFE) Exceeds Market Returns: Some Facts to Consider
Zacks via Yahoo Finance· 4 days agoWe can also see... industry stood at 1.78 at the close of the market yesterday. The Large Cap...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 1 day agoSince 2000, our top stock-picking strategies have blown away the S&P's +7.0 average gain per year....
7,403 Shares in Pfizer Inc. (NYSE:PFE) Bought by Gerber LLC
ETF DAILY NEWS· 6 days agoGerber LLC bought a new position in Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 7,403 shares of the biopharmaceutical ...
Best Blue Chip Stocks To Buy in June 2024
GoBankingRates via AOL· 5 days agoBlue chip stocks are among the safest and most secure buys that investors can add to their portfolios. Here are some of the best blue chip stocks to...
Sarepta Catapults 30% After Hitting A 'Grand Slam' Approval In Muscular Dystrophy
Investor's Business Daily· 1 day agoSarepta stock rocketed Friday after hitting a "grand slam" approval that expands the market for its...
Moderna stock is lone omen of bird flu pandemic
Reuters· 5 days agoThe recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a Covid vaccine has seen its market value rise 40% since...
Biotech With 345% Run Posts A 'Clear Win' In Cancer Treatment
Investor's Business Daily· 5 days agoThe company tested its treatment, dubbed NX-5948, in patients with relapsed or refractory forms of...
Gilead (GILD) Up as Twice-Yearly HIV Shot Prevents Infection
Zacks via Yahoo Finance· 1 day agoGilead's (GILD) twice-yearly, subcutaneous lenacapavir has demonstrated its potential as a new tool...
Arvinas announces new R&D leadership appointments By Investing.com
Investing.com· 5 days agoToday, Arvinas, Inc. (NASDAQ:ARVN), a pharmaceutical company specializing in the development of new...